Skip to main content
SpringerLink
Log in

Validating margin status in lung wedge resection for clinical stage I non-small cell lung cancer

  • Short Communication
  • Published:
Surgery Today Aims and scope Submit manuscript

Abstract

Stage I non-small cell lung cancer (NSCLC) is a localized disease without metastasis; therefore, it can be treated effectively with local therapies. Pulmonary resection is the most frequent treatment, performed as pulmonary wedge resection, segmentectomy, lobectomy, or pneumonectomy. Some retrospective clinical studies of pulmonary wedge resection suggest that its outcome may be inferior to that of anatomical pulmonary resection, whereas other recent studies, which assess surgical margin status, leveled acceptable outcomes. Since the outcome of pulmonary wedge resection for lung cancer may depend on tumor size, distance from the surgical margin to the tumor, tumor size/margin distance ratio, and margin cytology results, a prospective study assessing these parameters is ongoing. This will allow us to identify the clinical implications of these factors and predict which patients are likely to have a good outcome.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Masuda M, Kuwano H, Okumura M, Amano J, Arai H, Endo S, et al. Thoracic and cardiovascular surgery in Japan during 2012 annual report by The Japanese Association for Thoracic Surgery. Gen Thorac Cardiovasc Surg. 2014;62:734–64.

    Article  PubMed  PubMed Central  Google Scholar 

  2. Goldstraw P, Chansky K, Crowley J, Rami-Porta R, Asamura H, Eberhardt WE, et al. The IASLC lung cancer staging project: proposals for revision of the TNM stage groupings in the forthcoming (eighth) edition of the TNM classification for lung cancer. J Thorac Oncol. 2016;11:39–51.

    Article  PubMed  Google Scholar 

  3. Linden PA, D’Amico TA, Perry Y, Saha-Chaudhuri P, Sheng S, Kim S, et al. Quantifying the safety benefits of wedge resection: a society of thoracic surgery database propensity-matched analysis. Ann Thorac Surg. 2014;98:1705–11.

    Article  PubMed  Google Scholar 

  4. Miller JI, Hatcher CR Jr. Limited resection of bronchogenic carcinoma in the patients with marked impairment of pulmonary function. Ann Thorac Surg. 1987;44:340–3.

    Article  PubMed  CAS  Google Scholar 

  5. Errett LE, Wilson J, Chiu RC, Munro DD. Wedge resection as an alternative procedure for peripheral bronchogenic carcinoma in poor-risk patients. J Thorac Cardiovasc Surg. 1985;90:656–61.

    PubMed  CAS  Google Scholar 

  6. Landreneau RJ, Sugarbaker DJ, Mack MJ, Hazelrigg SR, Luketich JD, Fetterman L, et al. Wedge resection versus lobectomy for stage I (T1 N0 M0) non-small-cell lung cancer. J Thorac Cardiovasc Surg. 1997;113:691–700.

    Article  PubMed  CAS  Google Scholar 

  7. Griffin JP, Eastridge CE, Tolley EA, Pate JW. Wedge resection for non-small cell lung cancer in patients with pulmonary insufficiency: prospective ten-year survival. J Thorac Oncol. 2006;1:960–4.

    Article  PubMed  Google Scholar 

  8. Yendamuri S, Komaki RR, Correa AM, Allen P, Wynn B, Blackmon S, et al. Comparison of limited surgery and three-dimensional conformal radiation in high-risk patients with stage I non-small cell lung cancer. J Thorac Oncol. 2007;2:1022–8.

    Article  PubMed  Google Scholar 

  9. Kraev A, Rassias D, Vetto J, Torosoff M, Ravichandran P, Clement C, et al. Wedge resection vs lobectomy: 10-year survival in stage I primary lung cancer. Chest. 2007;131:136–40.

    Article  PubMed  Google Scholar 

  10. Grills IS, Mangona VS, Welsh R, Chmielewski G, McInerney E, Martin S, et al. Outcomes after stereotactic lung radiotherapy or wedge resection for stage I non-small-cell lung cancer. J Clin Oncol. 2010;28:928–35.

    Article  PubMed  Google Scholar 

  11. El-Sherif A, Fernando HC, Santos R, Pettiford B, Luketich JD, Close JM, et al. Margin and local recurrence after sublobar resection of non-small cell lung cancer. Ann Surg Oncol. 2007;14:2400–5.

    Article  PubMed  Google Scholar 

  12. Wisnivesky JP, Henschke CI, Swanson S, Yankelevitz DF, Zulueta J, Marcus S, et al. Limited resection for the treatment of patients with stage IA lung cancer. Ann Surg. 2010 Mar;251(3):550–4.

    Article  PubMed  Google Scholar 

  13. Nakamura H, Taniguchi Y, Miwa K, Adachi Y, Fujioka S, Haruki T, et al. Comparison of the surgical outcomes of thoracoscopic lobectomy, segmentectomy, and wedge resection for clinical stage I non-small cell lung cancer. Thorac Cardiovasc Surg. 2011;59:137–41.

    Article  PubMed  CAS  Google Scholar 

  14. Sawabata N, Maeda H, Matsumura A, Ohta M, Okumura M. Clinical implications of the margin cytology findings and margin/tumor size ratio in patients who underwent pulmonary excision for peripheral non-small cell lung cancer. Surg Today. 2012;42:238–44.

    Article  PubMed  Google Scholar 

  15. Matsuo Y, Chen F, Hamaji M, Kawaguchi A, Ueki N, Nagata Y, et al. Comparison of long-term survival outcomes between stereotactic body radiotherapy and sublobar resection for stage I non-small-cell lung cancer in patients at high risk for lobectomy: a propensity score matching analysis. Eur J Cancer. 2014;50:2932–8.

    Article  PubMed  Google Scholar 

  16. Mediratta N, Shackcloth M, Page R, Woolley S, Asante-Siaw J, Poullis M. Should males ever undergo wedge resection for stage 1 non-small-cell lung cancer? A propensity analysis. Eur J Cardiothorac Surg. 2014;46:267–73.

    Article  PubMed  Google Scholar 

  17. Ambrogi MC, Fanucchi O, Dini P, Melfi F, Davini F, Lucchi M, et al. Wedge resection and radiofrequency ablation for stage I nonsmall cell lung cancer. Eur Respir J. 2015;45:1089–97.

    Article  PubMed  Google Scholar 

  18. Fiorelli A, Caronia FP, Daddi N, Loizzi D, Ampollini L, Ardò N, et al. Sublobar resection versus lobectomy for stage I non-small cell lung cancer: an appropriate choice in elderly patients? Surg Today. 2016;46:1370–82.

    Article  PubMed  Google Scholar 

  19. Sawabata N, Miyaoka E, Asamura H, Nakanishi Y, Eguchi K, Mori M, et al. Japanese Joint Committee for Lung Cancer Registration. Japanese lung cancer registry study of 11,663 surgical cases in 2004: demographic and prognosis changes over decade. J Thorac Oncol. 2011;6:1229–35.

    Article  PubMed  Google Scholar 

  20. Sawabata N, Matsumura A, Ohota M, Maeda H, Hirano H, Nakagawa K, et al. Thoracic Surgery Study Group of Osaka University. Cytologically malignant margins of wedge resected stage I non-small cell lung cancer. Ann Thorac Surg. 2002;74:1953–7.

    Article  PubMed  Google Scholar 

  21. Sawabata N, Karube Y, Umezu H, Tamura M, Seki N, Ishihama H, et al. Cytologically malignant margin without continuous pulmonary tumor lesion: cases of wedge resection, segmentectomy and lobectomy. Interact Cardiovasc Thorac Surg. 2008;7:1044–8.

    Article  PubMed  Google Scholar 

  22. Sawabata N, Ohta M, Matsumura A, Nakagawa K, Hirano H, Maeda H, et al. Thoracic Surgery Study Group of Osaka University. Optimal distance of malignant negative margin in excision of non-small cell lung cancer: a multicenter prospective study. Ann Thorac Surg. 2004;77:415–20.

    Article  PubMed  Google Scholar 

  23. Maurizi G, D’Andrilli A, Ciccone AM, Ibrahim M, Andreetti C, Tierno S, et al. Margin distance does not influence recurrence and survival after wedge resection for lung cancer. Ann Thorac Surg. 2015;100:918–24.

    Article  PubMed  Google Scholar 

  24. Mohiuddin K, Haneuse S, Sofer T, Gill R, Jaklitsch MT, Colson YL, et al. Relationship between margin distance and local recurrence among patients undergoing wedge resection for small (≤ 2 cm) non-small cell lung cancer. J Thorac Cardiovasc Surg. 2014;147:1169–75.

    Article  PubMed  Google Scholar 

  25. Wolf A, Swanson SJ, Yip R, Liu B, Tarras ES, Yankelevitz BF, et al. The impact of margins on outcomes after wedge resection for stage I non-small cell lung cancer. Ann Thorac Surg. 2017;104:1171–8.

    Article  PubMed  Google Scholar 

  26. Altorki NK, Kamel MK, Narula N, Ghaly G, Nasar A, Rahouma M, et al. Anatomical segmentectomy and wedge resections are associated with comparable outcomes for patients with small cT1N0 non-small cell lung cancer. J Thorac Oncol. 2016;11:1984–92.

    Article  PubMed  Google Scholar 

  27. Smith CB, Swanson SJ, Mhango G, Wisnivesky JP. Survival after segmentectomy and wedge resection in stage I non-small-cell lung cancer. J Thorac Oncol. 2013;8:73–8.

    Article  PubMed  Google Scholar 

  28. Ginsberg RJ, Rubinstein LV. Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group. Ann Thorac Surg. 1995;60:615–22.

    Article  PubMed  CAS  Google Scholar 

  29. Nakamura K, Saji H, Nakajima R, Okada M, Asamura H, Shibata T, et al. A phase III randomized trial of lobectomy versus limited resection for small-sized peripheral non-small cell lung cancer (JCOG0802/WJOG4607L). Jpn J Clin Oncol. 2010;40:271–4.

    Article  PubMed  Google Scholar 

  30. Suzuki K, Watanabe S, Mizusawa J, Moriya Y, Yoshino I, Tsuboi M, et al. Japan Lung Cancer Surgical Study Group (JCOG LCSSG). Predictors of non-neoplastic lesions in lung tumours showing ground-glass opacity on thin-section computed tomography based on a multi-institutional prospective study. Interact Cardiovasc Thorac Surg. 2015;21:218–23.

    Article  PubMed  Google Scholar 

  31. Aokage K, Yoshida J, Hishida T, Tsuboi M, Saji H, Okada M, et al. Limited resection for early-stage non-small cell lung cancer as function-preserving radical surgery: a review. Jpn J Clin Oncol. 2016;47:7–11.

    Article  PubMed  Google Scholar 

  32. Kohman LJ, Gu L, Altorki N, Scalzetti E, Veit LJ, Wallen JM, et al. Biopsy first: lessons learned from Cancer and Leukemia Group B (CALGB) 140503. J Thorac Cardiovasc Surg. 2017;153:1592–7.

    Article  PubMed  PubMed Central  Google Scholar 

  33. Fernando HC, Landreneau RJ, Mandrekar SJ, Nichols FC, Hillman SL, Heron DE, et al. Impact of brachytherapy on local recurrence rates after sublobar resection: results from ACOSOG Z4032 (Alliance), a phase III randomized trial for high-risk operable non-small-cell lung cancer. J Clin Oncol. 2014;32:2456–62.

    Article  PubMed  PubMed Central  Google Scholar 

  34. Takahashi N, Sawabata N, Kawamura M, Ohtsuka T, Horio H, Sakaguchi H, et al. Multicenter prospective study of sublobar resection for c-stage I non-small cell lung cancer patients unable to undergo lobectomy (KLSG-0801): complete republication. Gen Thorac Cardiovasc Surg. 2016;64:470–5.

    Article  PubMed  Google Scholar 

  35. International Lung-Clinical-Study Organization/Kanetsu Lung Cancer Study Group. The prospective observational study of lung wedge resection for cT1a,1bN0M0 non-small lung cancer patients. 2018. https://upload.umin.ac.jp/cgi-open-bin/ctr/ctr.cgi?function=brows&action=brows&recptno=R000027991&type=summary&language=J. Accessed 20 Mar 2018.

  36. Lewis RJ, Caccavale RJ, Sisler GE, Mackenzie JW. Video-assisted thoracic surgical resection of malignant lung tumors. J Thorac Cardiovasc Surg. 1992;104:1679–85.

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Thoracic and Cardiovascular Surgery, Nara Medical University School of Medicine, Nara Medical University Hospital, Nara Medical University, 840 Shijo-cho, Kashihara City, Nara, 634-8522, Japan

    Noriyoshi Sawabata & Takeshi Kawaguchi

  2. General Thoracic Surgery, Hoshigaoka Medical Center, Hirakata, Japan

    Noriyoshi Sawabata

  3. First Department of Surgery, Hamamatsu Medical University School of Medicine, Hamamatzu, Japan

    Akikazu Kawase

  4. Department of Respiratory Surgery, Saitama Cardiovascular and Respiratory Center, Kumagaya, Japan

    Nobumasa Takahashi & Yuichi Saito

  5. Department of Surgery, Yokohama City University Hospital, Yokohama, Japan

    Tetsukan Woo

  6. Department Thoracic Surgery, Yamagata Prefectural Central Hospital, Yamagata, Japan

    Satoshi Shiono

  7. Department of Surgery, Teikyo University Hospital, Kawasaki, Japan

    Noriyuki Matsutani

Authors
  1. Noriyoshi Sawabata
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Akikazu Kawase
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Nobumasa Takahashi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Takeshi Kawaguchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Tetsukan Woo
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Yuichi Saito
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Satoshi Shiono
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Noriyuki Matsutani
    View author publications

    You can also search for this author in PubMed Google Scholar

Consortia

From The International Lung-Clinical-Study Organization (ILO)

Corresponding author

Correspondence to Noriyoshi Sawabata.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Sawabata, N., Kawase, A., Takahashi, N. et al. Validating margin status in lung wedge resection for clinical stage I non-small cell lung cancer. Surg Today 48, 963–967 (2018). https://doi.org/10.1007/s00595-018-1683-2

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00595-018-1683-2

Keywords

Search

Navigation